Viewing Study NCT03148132

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2026-01-27 @ 3:58 PM
Study NCT ID: NCT03148132
Status: COMPLETED
Last Update Posted: 2019-01-09
First Post: 2017-05-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP
Sponsor: Universidad Autonoma de San Luis Potosí
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Retinopathy of Prematurity Both Eyes View
None Retinal Disease View
None Premature Birth View
None Eye Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Retinopathy of Prematurity View
None VEGF View
None Bevacizumab View
None Ranibizumab View